23.97
前日終値:
$24.36
開ける:
$24.2
24時間の取引高:
4.77M
Relative Volume:
0.73
時価総額:
$12.39B
収益:
$11.32B
当期純損益:
$-981.00M
株価収益率:
-12.27
EPS:
-1.9532
ネットキャッシュフロー:
$714.00M
1週間 パフォーマンス:
-0.13%
1か月 パフォーマンス:
-7.20%
6か月 パフォーマンス:
+44.22%
1年 パフォーマンス:
+4.67%
Baxter International Inc Stock (BAX) Company Profile
名前
Baxter International Inc
セクター
電話
(224) 948-2000
住所
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, RMD, MDLN, ALC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
BAX
Baxter International Inc
|
23.97 | 12.08B | 11.32B | -981.00M | 714.00M | -1.9532 |
|
ISRG
Intuitive Surgical Inc
|
414.52 | 138.47B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
180.16 | 50.07B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
RMD
Resmed Inc
|
225.98 | 32.02B | 5.54B | 1.52B | 1.74B | 10.37 |
|
MDLN
Medline Inc
|
35.45 | 30.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
ALC
Alcon Inc
|
63.00 | 31.16B | 10.63B | 819.00M | 1.59B | 1.6577 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-31 | ダウングレード | Argus | Buy → Hold |
| 2025-08-04 | ダウングレード | Stifel | Buy → Hold |
| 2025-08-01 | ダウングレード | Goldman | Buy → Neutral |
| 2025-02-26 | 再開されました | Goldman | Buy |
| 2025-02-24 | アップグレード | Argus | Hold → Buy |
| 2025-02-20 | 再開されました | Barclays | Overweight |
| 2024-07-15 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | 開始されました | Goldman | Neutral |
| 2024-05-10 | ダウングレード | TD Cowen | Buy → Hold |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-01-06 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-12-19 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-12-15 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-12-12 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-06-24 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | ダウングレード | Goldman | Neutral → Sell |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-02-18 | 繰り返されました | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | 繰り返されました | Morgan Stanley | Overweight |
| 2022-02-18 | 繰り返されました | Raymond James | Outperform |
| 2022-02-18 | 繰り返されました | Stifel | Buy |
| 2022-02-18 | 繰り返されました | UBS | Neutral |
| 2022-02-18 | 繰り返されました | Wells Fargo | Overweight |
| 2022-02-11 | 開始されました | Goldman | Neutral |
| 2022-01-07 | 再開されました | Citigroup | Buy |
| 2022-01-07 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | アップグレード | Cowen | Market Perform → Outperform |
| 2021-09-03 | アップグレード | Barclays | Equal Weight → Overweight |
| 2021-05-25 | 開始されました | Barclays | Equal Weight |
| 2021-01-29 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | ダウングレード | UBS | Buy → Neutral |
| 2020-12-15 | ダウングレード | Goldman | Buy → Neutral |
| 2020-10-01 | アップグレード | Citigroup | Neutral → Buy |
| 2020-09-04 | ダウングレード | Argus | Buy → Hold |
| 2020-06-24 | 開始されました | Oppenheimer | Outperform |
| 2020-03-19 | アップグレード | Stifel | Hold → Buy |
| 2020-03-18 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | 開始されました | Citigroup | Neutral |
| 2020-02-13 | 開始されました | Goldman | Buy |
| 2020-01-02 | アップグレード | Evercore ISI | In-line → Outperform |
| 2019-12-17 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-01-02 | アップグレード | Citigroup | Neutral → Buy |
| 2019-01-02 | アップグレード | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | アップグレード | Argus | Hold → Buy |
| 2018-10-16 | 開始されました | Barclays | Underweight |
| 2018-05-17 | 再開されました | Piper Jaffray | Overweight |
| 2018-02-06 | 繰り返されました | Citigroup | Neutral |
| 2018-01-03 | 開始されました | Evercore ISI | Outperform |
| 2018-01-03 | アップグレード | Raymond James | Mkt Perform → Outperform |
すべてを表示
Baxter International Inc (BAX) 最新ニュース
Can Execution Lift Baxter International (NYSE:BAX) From Here? - Kalkine Media
Baxter International stock: Company releases Connected Hospital Report on September 30, 2026 - AD HOC NEWS
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
What Investors Might Be Missing On Baxter International (BAX) - Yahoo Finance
Baxter Releases Inaugural Connected Hospital Report - Business Wire
Baxter International stock faces a Q3 EPS estimate cut - AD HOC NEWS
Why Investors Need to Take Advantage of These 2 Medical Stocks Now - Zacks Investment Research
Baxter International stock trades above analyst target - AD HOC NEWS
Baxter International (BAX) Q1 2026 Earnings Call Transcript - Fortune
Baxter International (BAX) Q2 2026 Earnings Call Transcript - Fortune
Baxter International stock heads into the open after a 1.9 percent S&P 500 drop - AD HOC NEWS
Here's Why You Should Retain Baxter Stock in Your Portfolio for Now - Eastern Progress
Baxter International stock heads into the open after a 1.2 percent drop - AD HOC NEWS
Baxter International stock holds at USD 22.93 as storm damage weighs - AD HOC NEWS
A Look at Baxter International Inc (BAX) After 3.3% Gain -- GF V - GuruFocus
Baxter International Inc (BAX) Stock Price Today: $23.74 - Pluang
How Baxter International's WNC plant rebuilt post-Helene | Video - The Asheville Citizen Times
Baxter International, McDowell County - Yahoo
Baxter plant's Helene recovery has a human face - The Asheville Citizen Times
Baxter International stock holds near its yearly high - AD HOC NEWS
Baxter International stock gains 0.57 percent ahead of the open - AD HOC NEWS
Baxter International stock gains on cautious analyst tone - AD HOC NEWS
Is Baxter Stock Underperforming the Nasdaq? - Barchart.com
Top 3 Health Care Stocks That May Rocket Higher In September - Benzinga
Baxter International Inc. (BAX) Stock Analysis: Assessing a 26% Potential Upside Amid Healthcare Sector Challenges - DirectorsTalk Interviews
Baxter International stock reacts to guidance after second-quarter 2026 results - AD HOC NEWS
Baxter International stock slips as Q2 beat and raise still matters - AD HOC NEWS
Baxter International stock steadies near recent lows as analysts stick with Hold ratings - AD HOC NEWS
Baxter International stock heads into the open after a 0.8% dip - AD HOC NEWS
Baxter International stock heads into the open after a 0.6% dip - AD HOC NEWS
Baxter International stock rises on 24.5 percent YTD gain - AD HOC NEWS
Baxter International stock heads into the open after a 24.5 percent year-to-date gain - AD HOC NEWS
Baxter International Inc. (BAX) Stock Analysis: Exploring The 20.7% Upside Potential - DirectorsTalk Interviews
Baxter International Inc Share PriceBAX, RNS News, Articles, Quotes, & Charts (NYSE:BAX) - Proactive financial news
Securities Lawsuit Alert: Baxter International, Inc. (BAX) – Contact Levi & Korsinsky Before December 15, 2025 - ACCESS Newswire
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
Baxter: This Turnaround Stock Is Up and Still 38% Undervalued - morningstar.com
Baxter International stock heads into the open after a modest gain - ad-hoc-news.de
Baxter International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Transcript : Baxter International Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 12 - marketscreener.com
Baxter at Wells Fargo conference: growth improves as turnaround continues By Investing.com - Investing.com UK
A Look at Baxter International Inc (BAX) After 3.8% Decline -- G - GuruFocus
Baxter International stock trades sideways as technical signals flag limited near-term upside - ad-hoc-news.de
Baxter International Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Baxter International stock holds steady as investors await next earnings signal - ad-hoc-news.de
BAX Raises 2026 Outlook as Strong Q2 Growth Offsets Margin Pressure - Yahoo Finance
Human Albumin Market Report Analyzes Growth Factors, Challenges, and Market Dynamics - openPR.com
Don't Ignore The Insider Selling In Abeona Therapeutics - simplywall.st
Baxter International Inc. (BAX) Stock Analysis: Exploring Potential Upside and Analyst Ratings - DirectorsTalk Interviews
Nagaraj Bhat Appointed Vice President/GM, Global Capability Center (GCC) Site Leader at DePuy Synthes - hrtoday.in
Baxter International stock holds steady as investors focus on recent restructuring and earnings prof - ad-hoc-news.de
Baxter International Inc (BAX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):